Cleburne, Texas (PRWEB) November 05, 2014
For Immediate Release:
Boval, a leading manufacturer in proteins for cell culture research, has purchased an additional lyophilizer nearly doubling its capacity.
"We have seen a consistent increase in demand that prompted us to invest in additional lyophilization capabilities," says company Vice President of Engineering, Ron Gohdes. "The new lyophilizer will increase capacity by 83% and will represent 45% of our total capacity. It is also the same brand and type of equipment as our two current lyophiziers to streamline maintenance."
Director of Biological Operations Chris Utton also commented, "This is a large project for Boval but is in response to the growing needs of our clients. We are ecstatic about meeting those needs with increased capacity and fully expect the lyo to be installed and validated by the first quarter of 2015."
Questions concerning the expansion should be directed toward Mr. Gohdes, who can be reached at ronaldg[at]bovalco.com.